TOVX logo

Theriva Biologics (TOVX) Current Assets

Annual Current Assets

$27.40 M
-$18.12 M-39.80%

31 December 2023

TOVX Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$19.53 M
-$182.00 K-0.92%

01 September 2024

TOVX Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TOVX Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.8%-43.8%
3 y3 years+245.4%-71.6%
5 y5 years+66.8%+18.9%

TOVX Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-60.2%+245.4%-71.6%at low
5 y5 years-60.2%+245.4%-75.2%+193.2%
alltimeall time-60.2%>+9999.0%-75.2%

Theriva Biologics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$19.53 M(-0.9%)
June 2024
-
$19.71 M(-9.0%)
Mar 2024
-
$21.66 M(-21.0%)
Dec 2023
$27.82 M(+5.6%)
$27.40 M(-21.2%)
Sept 2023
-
$34.77 M(-8.4%)
June 2023
-
$37.97 M(-5.8%)
Mar 2023
-
$40.30 M(-11.5%)
Dec 2022
$26.34 M(+1647.9%)
$45.52 M(-13.7%)
Sept 2022
-
$52.73 M(-3.9%)
June 2022
-
$54.89 M(-7.8%)
Mar 2022
-
$59.55 M(-13.5%)
Dec 2021
$1.51 M(+216.6%)
-
Dec 2021
-
$68.86 M(-6.4%)
Sept 2021
-
$73.56 M(-2.7%)
June 2021
-
$75.63 M(-3.8%)
Mar 2021
-
$78.64 M(+891.1%)
Dec 2020
$476.00 K(-41.2%)
$7.93 M(+19.1%)
Sept 2020
-
$6.66 M(-25.6%)
June 2020
-
$8.96 M(-19.8%)
Mar 2020
-
$11.17 M(-32.0%)
Dec 2019
$809.00 K(+28.4%)
$16.43 M(-17.2%)
Sept 2019
-
$19.84 M(-13.8%)
June 2019
-
$23.01 M(-10.0%)
Mar 2019
-
$25.55 M(-13.4%)
Dec 2018
$630.00 K(-29.6%)
$29.51 M(+192.0%)
Sept 2018
-
$10.11 M(+31.9%)
June 2018
-
$7.66 M(-34.2%)
Mar 2018
-
$11.64 M(-35.1%)
Dec 2017
$895.00 K(-3.6%)
$17.94 M(-19.6%)
Sept 2017
-
$22.31 M(+49.6%)
June 2017
-
$14.92 M(-11.4%)
Mar 2017
-
$16.84 M(-21.9%)
Dec 2016
$928.00 K(+82.7%)
$21.57 M(+182.3%)
Sept 2016
-
$7.64 M(-51.7%)
June 2016
-
$15.82 M(-28.8%)
Mar 2016
-
$22.22 M(-26.8%)
Dec 2015
$508.00 K(+615.5%)
$30.34 M(-28.0%)
Sept 2015
-
$42.14 M(+259.8%)
June 2015
-
$11.71 M(-14.0%)
Mar 2015
-
$13.62 M(-28.6%)
Dec 2014
$71.00 K(+73.2%)
$19.07 M(+308.6%)
Sept 2014
-
$4.67 M(-49.4%)
June 2014
-
$9.23 M(-26.1%)
Mar 2014
-
$12.49 M(-23.0%)
Dec 2013
$41.00 K(-95.7%)
$16.22 M(+138.8%)
Sept 2013
-
$6.79 M(-28.2%)
June 2013
-
$9.46 M(-17.4%)
Mar 2013
-
$11.45 M(-8.1%)
Dec 2012
$960.00 K(+171.2%)
$12.46 M(+157.0%)
Sept 2012
-
$4.85 M(-22.7%)
June 2012
-
$6.27 M(-14.4%)
Mar 2012
-
$7.33 M(+2.9%)
Dec 2011
$354.00 K(-37.5%)
$7.12 M(-12.0%)
Sept 2011
-
$8.09 M(-9.1%)
June 2011
-
$8.91 M(+35.3%)
Mar 2011
-
$6.58 M(+85.7%)
Dec 2010
$566.00 K
$3.54 M(-4.2%)
DateAnnualQuarterly
Sept 2010
-
$3.70 M(+7.5%)
June 2010
-
$3.44 M(+66.1%)
Mar 2010
-
$2.07 M(-24.7%)
Dec 2009
$1.32 M(-9.4%)
$2.75 M(-24.7%)
Sept 2009
-
$3.66 M(-19.0%)
June 2009
-
$4.51 M(-15.7%)
Mar 2009
-
$5.36 M(-9.6%)
Dec 2008
$1.46 M(-29.8%)
$5.93 M(-8.7%)
Sept 2008
-
$6.49 M(-13.6%)
June 2008
-
$7.52 M(-15.0%)
Mar 2008
-
$8.85 M(-23.5%)
Dec 2007
$2.08 M(+598.5%)
$11.56 M(+56.8%)
Sept 2007
-
$7.37 M(-19.3%)
June 2007
-
$9.13 M(-16.8%)
Mar 2007
-
$10.97 M(-10.2%)
Dec 2006
$297.30 K(+5.4%)
$12.22 M(>+9900.0%)
Sept 2006
-
$0.00(0.0%)
June 2006
-
$0.00(0.0%)
Mar 2006
-
$0.00(-100.0%)
Dec 2005
$282.10 K(-58.5%)
-
Mar 2003
-
$574.10 K(-31.3%)
Dec 2002
$679.30 K(-0.6%)
$835.30 K(-21.5%)
Sept 2002
-
$1.06 M(-32.0%)
June 2002
-
$1.56 M(-5.1%)
Mar 2002
-
$1.65 M(+20.0%)
Dec 2001
$683.40 K(+26.3%)
$1.37 M(-48.0%)
Sept 2001
-
$2.64 M(-7.6%)
June 2001
-
$2.86 M(-7.3%)
Mar 2001
-
$3.08 M(-37.2%)
Dec 2000
$541.00 K(+6.2%)
$4.91 M(+67.3%)
Sept 2000
-
$2.93 M(-15.3%)
June 2000
-
$3.46 M(-40.7%)
Mar 2000
-
$5.84 M(+28.7%)
Dec 1999
$509.60 K(+94.1%)
$4.54 M(+249.2%)
Sept 1999
-
$1.30 M(-18.8%)
June 1999
-
$1.60 M(-23.8%)
Mar 1999
-
$2.10 M(-19.2%)
Dec 1998
$262.50 K(+31.3%)
$2.60 M(-10.3%)
Sept 1998
-
$2.90 M(-50.8%)
June 1998
-
$5.90 M(+5800.0%)
Mar 1998
-
$100.00 K(-80.0%)
Dec 1997
$200.00 K(-33.3%)
$500.00 K(-54.5%)
Sept 1997
-
$1.10 M(+37.5%)
June 1997
-
$800.00 K(-75.8%)
Mar 1997
-
$3.30 M(+32.0%)
Dec 1996
$300.00 K(+50.0%)
$2.50 M(-41.9%)
Sept 1996
-
$4.30 M(-17.3%)
June 1996
-
$5.20 M(+147.6%)
Mar 1996
-
$2.10 M(+5.0%)
Dec 1995
$200.00 K(-33.3%)
$2.00 M(-37.5%)
Sept 1995
-
$3.20 M(+3100.0%)
Dec 1994
$300.00 K(+200.0%)
$100.00 K(-97.8%)
Mar 1994
-
$4.60 M(+170.6%)
Dec 1993
$100.00 K
$1.70 M(-41.4%)
Sept 1993
-
$2.90 M(-34.1%)
June 1993
-
$4.40 M(-12.0%)
Mar 1993
-
$5.00 M

FAQ

  • What is Theriva Biologics annual total current assets?
  • What is the all time high annual current assets for Theriva Biologics?
  • What is Theriva Biologics annual current assets year-on-year change?
  • What is Theriva Biologics quarterly total current assets?
  • What is the all time high quarterly current assets for Theriva Biologics?
  • What is Theriva Biologics quarterly current assets year-on-year change?

What is Theriva Biologics annual total current assets?

The current annual current assets of TOVX is $27.40 M

What is the all time high annual current assets for Theriva Biologics?

Theriva Biologics all-time high annual total current assets is $68.86 M

What is Theriva Biologics annual current assets year-on-year change?

Over the past year, TOVX annual total current assets has changed by -$18.12 M (-39.80%)

What is Theriva Biologics quarterly total current assets?

The current quarterly current assets of TOVX is $19.53 M

What is the all time high quarterly current assets for Theriva Biologics?

Theriva Biologics all-time high quarterly total current assets is $78.64 M

What is Theriva Biologics quarterly current assets year-on-year change?

Over the past year, TOVX quarterly total current assets has changed by -$15.23 M (-43.82%)